Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1668 of 5804
-
Sleep tracking app may keep depression away after hospital stay
Disease control CompletedVery little is known of depressed patients' mental state after being discharged from inpatient wards where they are provided with a sheltered environment with stable sleep wake cycle, regular meals, and regular physical and social activities. Our previous usability study, SAFE I,…
Phase: NA • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Iceland launches massive screening study for early cancer detection
Knowledge-focused OngoingThis study will assess the benefits and harms of screening for monoclonal gammopathy of undetermined significance (MGUS). The overall and disease-specific mortality will be compared between screened and not screened participants. All individuals registered as inhabitants in Icela…
Phase: NA • Sponsor: University of Iceland • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Can a second stop be successful? nilotinib trial for CML relapse
Disease control OngoingThe main goal of the study is the assessment of duration of major molecular response (MMR) or better at 12 and 36 months after stopping tyrosine kinase inhibitors (TKI) therapy a second or third time in patients with at least three years prior TKI treatment comprising at least tw…
Phase: PHASE2 • Sponsor: European LeukemiaNet • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug combo aims to outsmart Platinum-Resistant ovarian cancer
Disease control OngoingThis randomized phase II trial studies how well ATR kinase inhibitor M6620 (M6620) and gemcitabine hydrochloride work compared to standard treatment with gemcitabine hydrochloride alone in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that has come …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Once-Daily pill could simplify CAH treatment
Disease control Recruiting nowThis is a controlled, open study designed to compare the effects of dual-release hydrocortisone preparations versus conventional glucocorticoid therapy on clinical, anthropometric parameters, metabolic syndrome, hormonal profile, bone status, quality of life, reproductive, sexual…
Phase: PHASE4 • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 26, 2026 17:55 UTC
-
Can the first 1,000 days stop obesity before it starts?
Prevention CompletedThe First 1000 Days (conception to age 2) is a crucial period for the development and prevention of obesity and its adverse consequences in mother-child pairs and their families. The overall aim of the First 1000 Days program is to work across early-life systems to prevent obesit…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
New combo therapy for lung cancer shows promise in early trial
Disease control CompletedThis phase I trial studies the side effects, best dose, and best way to give pembrolizumab when given together with paclitaxel, carboplatin, and radiation therapy in treating patients with stage II-IIIB non-small cell lung cancer. Monoclonal antibodies, such as pembrolizumab, may…
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Glow-in-the-Dark dye could help surgeons find hidden cancers
Diagnosis Recruiting nowThe overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers (adenocarcinoma) using the LUM Imaging System.
Phase: PHASE1, PHASE2 • Sponsor: Lumicell, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Brain zap study hopes to restore sight in the blind
Knowledge-focused OngoingIn this study, the investigators intend to evaluate the use of a commercially available neurostimulator system, NeuroPace RNS System to stimulate the visual cortex. The NeuroPace RNS System has a proven record of safety and reliability was approved by the FDA in November 2013. Th…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Air purifiers may give overweight kids with asthma extra relief
Disease control OngoingBackground: Asthma and obesity are public health crises that have concurrently risen over the past decades, affecting millions of children in the United States and disproportionately affecting low-income minority children in urban areas. The same children at highest risk for asth…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for myeloma patients with kidney issues: denosumab shows promise
Disease control CompletedThis research study is studying a possible therapy as a possible treatment for the consequences of Multiple Myeloma with renal insufficiency.
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New endoscopic heat treatment could help pancreatic cancer patients avoid surgery
Disease control Recruiting nowRadiofrequency ablation has been used for treatment of solid neoplasms of the liver, lung, kidney and adrenal. Recently, EUS-guided RFA has become available and the device allows EUS-guided treatment of pancreatic neoplasms. The procedure has been shown to be feasible in the porc…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Shorter, stronger radiation for prostate cancer: a new hope?
Disease control OngoingThe present study evaluates clinical outcomes and treatment-related toxicity following definitive ultra-high dose external beam radiotherapy delivered with two different regimens in patients with intermediate-risk adenocarcinoma of the prostate. Modern computer-driven technology …
Phase: PHASE1 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Personalized mutation tracking could spot relapse sooner in bone marrow cancer patients
Knowledge-focused CompletedThis study aims to develop highly sensitive methods for early detection of relapse based on the patients unique mutations. Initially, a mutational screen is being performed. Primers directed against these mutations will be constructed and presence of mutations will be followed in…
Sponsor: Nordic MDS Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
10,000 cancer patients join ontario Gene-Mapping effort to personalize care
Knowledge-focused Recruiting nowSubstantial progress has been made in the treatment of cancer through the use of targeted therapies, but what works for one patient might not work for another patient. Certain drugs are now being developed that target specific molecules in the body that are believed to be part of…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Targeted drug crizotinib tested against hard-to-treat cancers with MET gene change
Disease control OngoingThis phase II MATCH treatment trial tests how well crizotinib works in treating patients with solid tumors, lymphoma, or multiple myeloma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that does not respo…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Fat cells used to regrow jaw bone in first human trial
Disease control CompletedThe purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as a bone filler containing the patient's own (autologous) adipose (fat) tissue-derived cells in reconstructing bone in two clinical indications: 1. Bone augmentation (e.g. sinus augment…
Phase: PHASE1, PHASE2 • Sponsor: BonusBio Group Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Vitamin c may ward off Post-Surgery pain syndrome
Prevention CompletedVitamin C with its antioxidant role has many indications. The objective of this study is to demonstrate that taking vitamin C as a preventive significantly reduces the occurrence of complex regional pain syndrome (CRPS) type 1 in the aftermath of a scheduled surgery of the upper …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Can a simple iron infusion before heart surgery speed up recovery?
Disease control CompletedThis randomised double-blind, controlled phase IV trial will compare the efficacy, safety and cost-effectiveness of preoperative IV iron with placebo in patients with anaemia before elective cardiac surgery.
Phase: PHASE4 • Sponsor: Bayside Health • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Heart procedure may offer stroke prevention for patients who Can't take blood thinners
Disease control CompletedAtrial fibrillation (AF) is a frequent heart rhythm disorder, responsible for the formation of cardiac thrombi, which can embolize in the systemic circulation, responsible for strokes (Cerebrovascular accidents). AF increases the risk of stroke and stroke-related disability. Prev…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC